Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 132 entries
Sorted by: Best Match Show Resources per page
Retraction. Parkinsonism: a clinical marker of exposure to neurotoxins.

Neurotoxicology and teratology

Bleecker ML.
PMID: 2255298
Neurotoxicol Teratol. 1990 Nov-Dec;12(6):569. doi: 10.1016/0892-0362(90)90063-i.

No abstract available.

Cite
Bleecker ML. Retraction. Parkinsonism: a clinical marker of exposure to neurotoxins. Neurotoxicol Teratol. 1990;12(6):569doi: 10.1016/0892-0362(90)90063-i.
Bleecker, M. L. (1990). Retraction. Parkinsonism: a clinical marker of exposure to neurotoxins. Neurotoxicology and teratology, 12(6), 569. https://doi.org/10.1016/0892-0362(90)90063-i
Bleecker, M L. "Retraction. Parkinsonism: a clinical marker of exposure to neurotoxins." Neurotoxicology and teratology vol. 12,6 (1990): 569. doi: https://doi.org/10.1016/0892-0362(90)90063-i
Bleecker ML. Retraction. Parkinsonism: a clinical marker of exposure to neurotoxins. Neurotoxicol Teratol. 1990 Nov-Dec;12(6):569. doi: 10.1016/0892-0362(90)90063-i. PMID: 2255298.
Copy Download .nbib Format: NLM
Drug-induced falls in older persons: is there a role for therapeutic drug monitoring?.

Therapeutic advances in drug safety

Hartholt KA, Becker ML, van der Cammen TJ.
PMID: 27034772
Ther Adv Drug Saf. 2016 Apr;7(2):39-42. doi: 10.1177/2042098615627806. Epub 2016 Jan 20.

BACKGROUND: Falls are the leading cause of injuries among older persons. Because of ageing societies worldwide, falls are expected to become a prominent public health problem. The usage of several types of drugs has been associated with an increased...

Cite
Hartholt KA, Becker ML, van der Cammen TJ. Drug-induced falls in older persons: is there a role for therapeutic drug monitoring?. Ther Adv Drug Saf. 2016;7(2):39-42doi: 10.1177/2042098615627806.
Hartholt, K. A., Becker, M. L., & van der Cammen, T. J. (2016). Drug-induced falls in older persons: is there a role for therapeutic drug monitoring?. Therapeutic advances in drug safety, 7(2), 39-42. https://doi.org/10.1177/2042098615627806
Hartholt, Klaas A, et al. "Drug-induced falls in older persons: is there a role for therapeutic drug monitoring?." Therapeutic advances in drug safety vol. 7,2 (2016): 39-42. doi: https://doi.org/10.1177/2042098615627806
Hartholt KA, Becker ML, van der Cammen TJ. Drug-induced falls in older persons: is there a role for therapeutic drug monitoring?. Ther Adv Drug Saf. 2016 Apr;7(2):39-42. doi: 10.1177/2042098615627806. Epub 2016 Jan 20. PMID: 27034772; PMCID: PMC4785859.
Copy Download .nbib Format: NLM
Design of the Subpopulations and Intermediate Outcome Measures in COPD (SPIROMICS) AIR Study.

BMJ open respiratory research

Hansel NN, Paulin LM, Gassett AJ, Peng RD, Alexis N, Fan VS, Bleecker E, Bowler R, Comellas AP, Dransfield M, Han MK, Kim V, Krishnan JA, Pirozzi C, Cooper CB, Martinez F, Woodruff PG, Breysse PJ, Barr RG, Kaufman JD.
PMID: 28948026
BMJ Open Respir Res. 2017 May 18;4(1):e000186. doi: 10.1136/bmjresp-2017-000186. eCollection 2017.

INTRODUCTION: Population-based epidemiological evidence suggests that exposure to ambient air pollutants increases hospitalisations and mortality from chronic obstructive pulmonary disease (COPD), but less is known about the impact of exposure to air pollutants on patient-reported outcomes, morbidity and progression...

Cite
Hansel NN, Paulin LM, Gassett AJ, et al. Design of the Subpopulations and Intermediate Outcome Measures in COPD (SPIROMICS) AIR Study. BMJ Open Respir Res. 2017;4(1):e000186doi: 10.1136/bmjresp-2017-000186.
Hansel, N. N., Paulin, L. M., Gassett, A. J., Peng, R. D., Alexis, N., Fan, V. S., Bleecker, E., Bowler, R., Comellas, A. P., Dransfield, M., Han, M. K., Kim, V., Krishnan, J. A., Pirozzi, C., Cooper, C. B., Martinez, F., Woodruff, P. G., Breysse, P. J., Barr, R. G., & Kaufman, J. D. (2017). Design of the Subpopulations and Intermediate Outcome Measures in COPD (SPIROMICS) AIR Study. BMJ open respiratory research, 4(1), e000186. https://doi.org/10.1136/bmjresp-2017-000186
Hansel, Nadia N, et al. "Design of the Subpopulations and Intermediate Outcome Measures in COPD (SPIROMICS) AIR Study." BMJ open respiratory research vol. 4,1 (2017): e000186. doi: https://doi.org/10.1136/bmjresp-2017-000186
Hansel NN, Paulin LM, Gassett AJ, Peng RD, Alexis N, Fan VS, Bleecker E, Bowler R, Comellas AP, Dransfield M, Han MK, Kim V, Krishnan JA, Pirozzi C, Cooper CB, Martinez F, Woodruff PG, Breysse PJ, Barr RG, Kaufman JD. Design of the Subpopulations and Intermediate Outcome Measures in COPD (SPIROMICS) AIR Study. BMJ Open Respir Res. 2017 May 18;4(1):e000186. doi: 10.1136/bmjresp-2017-000186. eCollection 2017. PMID: 28948026; PMCID: PMC5595208.
Copy Download .nbib Format: NLM
An evaluation of 2,5-norbornadiene as a reversible inhibitor of ethylene action in deepwater rice.

Plant physiology

Bleecker AB, Rose-John S, Kende H.
PMID: 16665450
Plant Physiol. 1987 Jun;84(2):395-8. doi: 10.1104/pp.84.2.395.

Partial submergence of deepwater rice (Oryza sativa L. cv Habiganj Aman II) elicits three responses: enhancement of internodal elongation, inhibition of leaf growth, and promotion of adventitious root formation. All three responses can be induced in isolated stem sections...

Cite
Bleecker AB, Rose-John S, Kende H. An evaluation of 2,5-norbornadiene as a reversible inhibitor of ethylene action in deepwater rice. Plant Physiol. 1987;84(2):395-8doi: 10.1104/pp.84.2.395.
Bleecker, A. B., Rose-John, S., & Kende, H. (1987). An evaluation of 2,5-norbornadiene as a reversible inhibitor of ethylene action in deepwater rice. Plant physiology, 84(2), 395-8. https://doi.org/10.1104/pp.84.2.395
Bleecker, A B, et al. "An evaluation of 2,5-norbornadiene as a reversible inhibitor of ethylene action in deepwater rice." Plant physiology vol. 84,2 (1987): 395-8. doi: https://doi.org/10.1104/pp.84.2.395
Bleecker AB, Rose-John S, Kende H. An evaluation of 2,5-norbornadiene as a reversible inhibitor of ethylene action in deepwater rice. Plant Physiol. 1987 Jun;84(2):395-8. doi: 10.1104/pp.84.2.395. PMID: 16665450; PMCID: PMC1056590.
Copy Download .nbib Format: NLM
Length-dependent optical effects in single-wall carbon nanotubes.

Journal of the American Chemical Society

Fagan JA, Simpson JR, Bauer BJ, Lacerda SH, Becker ML, Chun J, Migler KB, Walker AR, Hobbie EK.
PMID: 17672462
J Am Chem Soc. 2007 Aug 29;129(34):10607-12. doi: 10.1021/ja073115c. Epub 2007 Aug 02.

Among the novel chemical and physical attributes of single-wall carbon nanotubes (SWCNTs), the optical properties are perhaps the most compelling. Although much is known about how such characteristics depend on nanotube chirality and diameter, relatively little is known about...

Cite
Fagan JA, Simpson JR, Bauer BJ, et al. Length-dependent optical effects in single-wall carbon nanotubes. J Am Chem Soc. 2007;129(34):10607-12doi: 10.1021/ja073115c.
Fagan, J. A., Simpson, J. R., Bauer, B. J., Lacerda, S. H., Becker, M. L., Chun, J., Migler, K. B., Walker, A. R., & Hobbie, E. K. (2007). Length-dependent optical effects in single-wall carbon nanotubes. Journal of the American Chemical Society, 129(34), 10607-12. https://doi.org/10.1021/ja073115c
Fagan, Jeffrey A, et al. "Length-dependent optical effects in single-wall carbon nanotubes." Journal of the American Chemical Society vol. 129,34 (2007): 10607-12. doi: https://doi.org/10.1021/ja073115c
Fagan JA, Simpson JR, Bauer BJ, Lacerda SH, Becker ML, Chun J, Migler KB, Walker AR, Hobbie EK. Length-dependent optical effects in single-wall carbon nanotubes. J Am Chem Soc. 2007 Aug 29;129(34):10607-12. doi: 10.1021/ja073115c. Epub 2007 Aug 02. PMID: 17672462.
Copy Download .nbib Format: NLM
Strain-Promoted Crosslinking of PEG-based Hydrogels via Copper-Free Cycloaddition.

ACS macro letters

Zheng J, Smith Callahan LA, Hao J, Guo K, Wesdemiotis C, Weiss RA, Becker ML.
PMID: 23205321
ACS Macro Lett. 2012 Aug 21;1(8):1071-1073. doi: 10.1021/mz3003775.

The synthesis of a 4-dibenzocyclooctynol (DIBO) functionalized polyethylene glycol (PEG) and fabrication of hydrogels via strain-promoted, metal-free, azide-alkyne cycloaddition is reported. The resulting hydrogel materials provide a versatile alternative in which to encapsulate cells that are sensitive to photochemical...

Cite
Zheng J, Smith Callahan LA, Hao J, et al. Strain-Promoted Crosslinking of PEG-based Hydrogels via Copper-Free Cycloaddition. ACS Macro Lett. 2012;1(8):1071-1073doi: 10.1021/mz3003775.
Zheng, J., Smith Callahan, L. A., Hao, J., Guo, K., Wesdemiotis, C., Weiss, R. A., & Becker, M. L. (2012). Strain-Promoted Crosslinking of PEG-based Hydrogels via Copper-Free Cycloaddition. ACS macro letters, 1(8), 1071-1073. https://doi.org/10.1021/mz3003775
Zheng, Jukuan, et al. "Strain-Promoted Crosslinking of PEG-based Hydrogels via Copper-Free Cycloaddition." ACS macro letters vol. 1,8 (2012): 1071-1073. doi: https://doi.org/10.1021/mz3003775
Zheng J, Smith Callahan LA, Hao J, Guo K, Wesdemiotis C, Weiss RA, Becker ML. Strain-Promoted Crosslinking of PEG-based Hydrogels via Copper-Free Cycloaddition. ACS Macro Lett. 2012 Aug 21;1(8):1071-1073. doi: 10.1021/mz3003775. PMID: 23205321; PMCID: PMC3507357.
Copy Download .nbib Format: NLM
Developmental pharmacogenetics in pediatric rheumatology: utilizing a new paradigm to effectively treat patients with juvenile idiopathic arthritis with methotrexate.

Human genomics and proteomics : HGP

Becker ML, Leeder JS.
PMID: 20981233
Hum Genomics Proteomics. 2010 Jun 22;2010:257120. doi: 10.4061/2010/257120.

Although methotrexate is widely used in clinical practice there remains significant lack of understanding of its mechanisms of action and the factors that contribute to the variability in toxicity and response seen clinically. In addition to differences in drug...

Cite
Becker ML, Leeder JS. Developmental pharmacogenetics in pediatric rheumatology: utilizing a new paradigm to effectively treat patients with juvenile idiopathic arthritis with methotrexate. Hum Genomics Proteomics. 2010;2010:257120doi: 10.4061/2010/257120.
Becker, M. L., & Leeder, J. S. (2010). Developmental pharmacogenetics in pediatric rheumatology: utilizing a new paradigm to effectively treat patients with juvenile idiopathic arthritis with methotrexate. Human genomics and proteomics : HGP, 2010257120. https://doi.org/10.4061/2010/257120
Becker, Mara L, and Leeder, J Steven. "Developmental pharmacogenetics in pediatric rheumatology: utilizing a new paradigm to effectively treat patients with juvenile idiopathic arthritis with methotrexate." Human genomics and proteomics : HGP vol. 2010 (2010): 257120. doi: https://doi.org/10.4061/2010/257120
Becker ML, Leeder JS. Developmental pharmacogenetics in pediatric rheumatology: utilizing a new paradigm to effectively treat patients with juvenile idiopathic arthritis with methotrexate. Hum Genomics Proteomics. 2010 Jun 22;2010:257120. doi: 10.4061/2010/257120. PMID: 20981233; PMCID: PMC2958653.
Copy Download .nbib Format: NLM
Fluorinated copolymer nanoparticles for multimodal imaging applications.

Macromolecular rapid communications

Bailey MM, Mahoney CM, Dempah KE, Davis JM, Becker ML, Khondee S, Munson EJ, Berkland C.
PMID: 21590842
Macromol Rapid Commun. 2010 Jan 04;31(1):87-92. doi: 10.1002/marc.200900505. Epub 2009 Nov 03.

Nanomaterials have emerged as valuable tools in biomedical imaging techniques. Here, the synthesis and characterization of a novel fluorinated nanoparticle with potential applications as an MRI contrast agent is reported. Particles were synthesized using a free radical polymerization technique....

Cite
Bailey MM, Mahoney CM, Dempah KE, et al. Fluorinated copolymer nanoparticles for multimodal imaging applications. Macromol Rapid Commun. 2009;31(1):87-92doi: 10.1002/marc.200900505.
Bailey, M. M., Mahoney, C. M., Dempah, K. E., Davis, J. M., Becker, M. L., Khondee, S., Munson, E. J., & Berkland, C. (2010). Fluorinated copolymer nanoparticles for multimodal imaging applications. Macromolecular rapid communications, 31(1), 87-92. https://doi.org/10.1002/marc.200900505
Bailey, Mark M, et al. "Fluorinated copolymer nanoparticles for multimodal imaging applications." Macromolecular rapid communications vol. 31,1 (2010): 87-92. doi: https://doi.org/10.1002/marc.200900505
Bailey MM, Mahoney CM, Dempah KE, Davis JM, Becker ML, Khondee S, Munson EJ, Berkland C. Fluorinated copolymer nanoparticles for multimodal imaging applications. Macromol Rapid Commun. 2010 Jan 04;31(1):87-92. doi: 10.1002/marc.200900505. Epub 2009 Nov 03. PMID: 21590842.
Copy Download .nbib Format: NLM
Poly(ester urea)-Based Adhesives: Improved Deployment and Adhesion by Incorporation of Poly(propylene glycol) Segments.

ACS applied materials & interfaces

Zhou J, Bhagat V, Becker ML.
PMID: 27960413
ACS Appl Mater Interfaces. 2016 Dec 14;8(49):33423-33429. doi: 10.1021/acsami.6b09676. Epub 2016 Dec 06.

The adhesive nature of mussels arises from the catechol moiety in the 3,4-dihydroxyphenylalanine (DOPA) amino acid, one of the many proteins that contribute to the unique adhesion properties of mussels. Inspired by these properties, many biomimetic adhesives have been...

Cite
Zhou J, Bhagat V, Becker ML. Poly(ester urea)-Based Adhesives: Improved Deployment and Adhesion by Incorporation of Poly(propylene glycol) Segments. ACS Appl Mater Interfaces. 2016;8(49):33423-33429doi: 10.1021/acsami.6b09676.
Zhou, J., Bhagat, V., & Becker, M. L. (2016). Poly(ester urea)-Based Adhesives: Improved Deployment and Adhesion by Incorporation of Poly(propylene glycol) Segments. ACS applied materials & interfaces, 8(49), 33423-33429. https://doi.org/10.1021/acsami.6b09676
Zhou, Jinjun, et al. "Poly(ester urea)-Based Adhesives: Improved Deployment and Adhesion by Incorporation of Poly(propylene glycol) Segments." ACS applied materials & interfaces vol. 8,49 (2016): 33423-33429. doi: https://doi.org/10.1021/acsami.6b09676
Zhou J, Bhagat V, Becker ML. Poly(ester urea)-Based Adhesives: Improved Deployment and Adhesion by Incorporation of Poly(propylene glycol) Segments. ACS Appl Mater Interfaces. 2016 Dec 14;8(49):33423-33429. doi: 10.1021/acsami.6b09676. Epub 2016 Dec 06. PMID: 27960413.
Copy Download .nbib Format: NLM
Rural Residence and Chronic Obstructive Pulmonary Disease Exacerbations. Analysis of the SPIROMICS Cohort.

Annals of the American Thoracic Society

Burkes RM, Gassett AJ, Ceppe AS, Anderson W, O'Neal WK, Woodruff PG, Krishnan JA, Barr RG, Han MK, Martinez FJ, Comellas AP, Lambert AA, Kaufman JD, Dransfield MT, Wells JM, Kanner RE, Paine R, Bleecker ER, Paulin LM, Hansel NN, Drummond MB.
PMID: 29584453
Ann Am Thorac Soc. 2018 Jul;15(7):808-816. doi: 10.1513/AnnalsATS.201710-837OC.

No abstract available.

Cite
Burkes RM, Gassett AJ, Ceppe AS, et al. Rural Residence and Chronic Obstructive Pulmonary Disease Exacerbations. Analysis of the SPIROMICS Cohort. Ann Am Thorac Soc. 2018;15(7):808-816doi: 10.1513/AnnalsATS.201710-837OC.
Burkes, R. M., Gassett, A. J., Ceppe, A. S., Anderson, W., O'Neal, W. K., Woodruff, P. G., Krishnan, J. A., Barr, R. G., Han, M. K., Martinez, F. J., Comellas, A. P., Lambert, A. A., Kaufman, J. D., Dransfield, M. T., Wells, J. M., Kanner, R. E., Paine, R., Bleecker, E. R., Paulin, L. M., Hansel, N. N., Drummond, M. B. (2018). Rural Residence and Chronic Obstructive Pulmonary Disease Exacerbations. Analysis of the SPIROMICS Cohort. Annals of the American Thoracic Society, 15(7), 808-816. https://doi.org/10.1513/AnnalsATS.201710-837OC
Burkes, Robert M, et al. "Rural Residence and Chronic Obstructive Pulmonary Disease Exacerbations. Analysis of the SPIROMICS Cohort." Annals of the American Thoracic Society vol. 15,7 (2018): 808-816. doi: https://doi.org/10.1513/AnnalsATS.201710-837OC
Burkes RM, Gassett AJ, Ceppe AS, Anderson W, O'Neal WK, Woodruff PG, Krishnan JA, Barr RG, Han MK, Martinez FJ, Comellas AP, Lambert AA, Kaufman JD, Dransfield MT, Wells JM, Kanner RE, Paine R, Bleecker ER, Paulin LM, Hansel NN, Drummond MB. Rural Residence and Chronic Obstructive Pulmonary Disease Exacerbations. Analysis of the SPIROMICS Cohort. Ann Am Thorac Soc. 2018 Jul;15(7):808-816. doi: 10.1513/AnnalsATS.201710-837OC. PMID: 29584453; PMCID: PMC6207115.
Copy Download .nbib Format: NLM
Natural killer cell-mediated inflammation resolution is disabled in severe asthma.

Science immunology

Duvall MG, Barnig C, Cernadas M, Ricklefs I, Krishnamoorthy N, Grossman NL, Bhakta NR, Fahy JV, Bleecker ER, Castro M, Erzurum SC, Gaston BM, Jarjour NN, Mauger DT, Wenzel SE, Comhair SA, Coverstone AM, Fajt ML, Hastie AT, Johansson MW, Peters MC, Phillips BR, Israel E, Levy BD.
PMID: 28783702
Sci Immunol. 2017 Mar 10;2(9). doi: 10.1126/sciimmunol.aam5446.

Severe asthma is typically characterized by chronic airway inflammation that is refractory to corticosteroids and associated with excess morbidity. Patients were recruited into the National Heart, Lung, and Blood Institute-sponsored Severe Asthma Research Program and comprehensively phenotyped by bronchoscopy....

Cite
Duvall MG, Barnig C, Cernadas M, et al. Natural killer cell-mediated inflammation resolution is disabled in severe asthma. Sci Immunol. 2017;2(9)doi: 10.1126/sciimmunol.aam5446.
Duvall, M. G., Barnig, C., Cernadas, M., Ricklefs, I., Krishnamoorthy, N., Grossman, N. L., Bhakta, N. R., Fahy, J. V., Bleecker, E. R., Castro, M., Erzurum, S. C., Gaston, B. M., Jarjour, N. N., Mauger, D. T., Wenzel, S. E., Comhair, S. A., Coverstone, A. M., Fajt, M. L., Hastie, A. T., Johansson, M. W., Peters, M. C., Phillips, B. R., Israel, E., Levy, B. D. (2017). Natural killer cell-mediated inflammation resolution is disabled in severe asthma. Science immunology, 2(9), . https://doi.org/10.1126/sciimmunol.aam5446
Duvall, Melody G, et al. "Natural killer cell-mediated inflammation resolution is disabled in severe asthma." Science immunology vol. 2,9 (2017). doi: https://doi.org/10.1126/sciimmunol.aam5446
Duvall MG, Barnig C, Cernadas M, Ricklefs I, Krishnamoorthy N, Grossman NL, Bhakta NR, Fahy JV, Bleecker ER, Castro M, Erzurum SC, Gaston BM, Jarjour NN, Mauger DT, Wenzel SE, Comhair SA, Coverstone AM, Fajt ML, Hastie AT, Johansson MW, Peters MC, Phillips BR, Israel E, Levy BD. Natural killer cell-mediated inflammation resolution is disabled in severe asthma. Sci Immunol. 2017 Mar 10;2(9). doi: 10.1126/sciimmunol.aam5446. PMID: 28783702; PMCID: PMC5561743.
Copy Download .nbib Format: NLM
Frequency of occurrence of medication discrepancies and associated risk factors in cases of acute hospital admission.

Pharmacy practice

Van Der Luit CD, De Jong IR, Ebbens MM, Euser S, Verweij SL, Van Den Bemt PM, Luttikhuis HM, Becker ML.
PMID: 30637032
Pharm Pract (Granada). 2018 Oct-Dec;16(4):1301. doi: 10.18549/PharmPract.2018.04.1301. Epub 2018 Dec 17.

BACKGROUND: Medication discrepancies are a common occurrence following hospital admission and carry the potential for causing harm. However, little is known about the potential risk factors involved in medication discrepancies.OBJECTIVE: The objective of this study was to determine how...

Cite
Van Der Luit CD, De Jong IR, Ebbens MM, et al. Frequency of occurrence of medication discrepancies and associated risk factors in cases of acute hospital admission. Pharm Pract (Granada). 2018;16(4):1301doi: 10.18549/PharmPract.2018.04.1301.
Van Der Luit, C. D., De Jong, I. R., Ebbens, M. M., Euser, S., Verweij, S. L., Van Den Bemt, P. M., Luttikhuis, H. M., & Becker, M. L. (2018). Frequency of occurrence of medication discrepancies and associated risk factors in cases of acute hospital admission. Pharmacy practice, 16(4), 1301. https://doi.org/10.18549/PharmPract.2018.04.1301
Van Der Luit, Charlotte D, et al. "Frequency of occurrence of medication discrepancies and associated risk factors in cases of acute hospital admission." Pharmacy practice vol. 16,4 (2018): 1301. doi: https://doi.org/10.18549/PharmPract.2018.04.1301
Van Der Luit CD, De Jong IR, Ebbens MM, Euser S, Verweij SL, Van Den Bemt PM, Luttikhuis HM, Becker ML. Frequency of occurrence of medication discrepancies and associated risk factors in cases of acute hospital admission. Pharm Pract (Granada). 2018 Oct-Dec;16(4):1301. doi: 10.18549/PharmPract.2018.04.1301. Epub 2018 Dec 17. PMID: 30637032; PMCID: PMC6322986.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 132 entries